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ABSTRACT
Background: Evidence on aerosol delivery via tracheostomy is lacking. The purpose of this
study was to evaluate the effect of aerosol device and administration technique on drug delivery
in a simulated spontaneously breathing pediatric model with tracheostomy.
Methods: Delivery efficiencies during spontaneous breathing with assisted and unassisted
administration techniques were compared using the jet nebulizer (JN- MicroMist), vibrating
mesh nebulizer (VMN- Aeroneb Solo) and pressurized metered-dose inhaler (pMDIProAirHFA). The direct administration of aerosols in spontaneously breathing patients
(unassisted technique) was compared to administration of aerosol therapy via a manual
resuscitation bag (assisted technique) attached to the aerosol delivery device and synchronized
with inspiration. An in-vitro lung model consisted of an uncuffed tracheostomy tube (4.5 mmID)
was attached to a collecting filter (Respirgard) which was connected to a dual-chamber test lung
(TTL) and a ventilator (Hamilton). The breathing parameters of a 2 years-old child were set at an
RR of 25 breaths/min, a Vt of 150 mL, a Ti of 0.8 sec and PIF of 20 L/min. Albuterol sulfate was
administered with each nebulizer (2.5 mg/3 ml) and pMDI with spacer (4 puffs, 108 µg/puff).
Each aerosol device was tested five times with both administration techniques (n=5). Drug
collected on the filter was eluted with 0.1 N HCl and analyzed via spectrophotometry.
Results: The amount of aerosol deposited in the filter was quantified and expressed as inhaled
mass and inhaled mass percent. The pMDI with spacer had the highest inhaled mass percent,
while the VMN had the highest inhaled mass. The results of this study also found that JN had the
least efficient aerosol device used in this study. The trend of higher deposition with unassisted
versus assisted administration of aerosol was not significant (p>0.05).

Conclusions: Drug deposited distal to the tracheostomy tube with JN was lesser than either
VMN or pMDI. Delivery efficiency was similar with unassisted and assisted aerosol
administration technique in this in vitro pediatric model.
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CHAPTER I
INTRODUCTION
Over the years, aerosol therapy has come to play an integral role in the treatment of
pediatric respiratory diseases. Inhaled aerosol agents such as bronchodilators, corticosteroids,
antibiotics, and mucolytics are commonly delivered to spontaneously breathing pediatric patients
with a tracheostomy. Administering therapeutic inhaled aerosols to pediatric patients is
challenging. The pediatric population ranges in age, which means patients with different airway
sizes, breathing patterns, and cooperation levels (Schüepp, Straub, Möller, & Wildhaber, 2004).
These patient-related factors impact the deposition of aerosol drugs in the lungs (Ari & Fink,
2011; Schüepp et al., 2004). The presence of an artificial airway such as a tracheostomy tube
(TT) or an endotracheal tube also influences the deposition of inhaled aerosols in the lungs (Ari,
Harwood, Sheard, & Fink, 2012). Therefore, it is important to select an efficient aerosol delivery
device and the proper administration technique to enhance aerosol deposition in pediatric
patients with a tracheostomy.
Aerosol delivery devices, such as jet nebulizers (JN) and pressurized metered dose
inhalers (pMDI) are the most common means of providing therapeutic inhaled aerosols to
pediatric patients with a tracheostomy (Willis & Berlinski, 2012). In addition, the vibrating mesh
nebulizer (VMN) is one of a group of new devices that has revolutionized the delivery of aerosol
drugs. Each of these devices (JN, pMDI and VMN) can be used either alone (unassisted
technique) or in conjunction with a manual resuscitation bag (assisted technique) to aid aerosol
delivery. Health care providers need information about the best way to deliver aerosol drugs to
pediatric patients who have a tracheostomy. Therefore, this study compares the amount of
aerosol drugs deposited in the lungs by each of these three aerosol delivery devices when using
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either the assisted or unassisted technique. This comparison can guide health care providers in
selecting the optimum method for aerosol delivery to pediatric patients with a tracheostomy,
which may result in a reduced drug dosage, a shorter treatment time, and a lower overall cost.
Few in vivo and in vitro studies have examined the delivery of aerosol therapy to
spontaneously breathing pediatric patients with a tracheostomy. By contrast, many researchers
have studied the administration of inhaled aerosols to either spontaneously breathing patients or
to mechanically ventilated patients through endotracheal tubes (Dhand, 2000, 2004; Duarte,
Fink, & Dhand, 2001; MacIntyre, 2002). To date, researchers have yet to determine which
device should be used among the pediatric patient population to optimize aerosol deposition via a
TT and no published study has evaluated the efficiency of a VMN as an aerosol delivery device
in spontaneously breathing pediatric patients with TTs. More research is needed that compares
assisted and unassisted administrative techniques on aerosol delivery to such patients. Therefore,
this study examines the efficiency of three different types of aerosol devices– a JN, a VMN, and
a pMDI– on aerosol deposition in a simulated spontaneously breathing pediatric model with a
tracheostomy. This research is also designed to compare the influence of assisted and unassisted
aerosol administration techniques on the amount of aerosol delivered to the pediatric model
developed in this study.
The following research questions provide the structure for this study:
1) What is the most efficient device for administering inhaled bronchodilators through a
pediatric TT (JN, VMN or pMDI)?
2) What is the best technique to administer inhaled bronchodilators via a pediatric TT
(assisted or unassisted technique)?
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CHAPTER II
LITERATURE REVIEW
This literature review presents articles focusing on the delivery of aerosol therapy
through a pediatric TT. The following search terms were used to collect articles from the
Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PubMed databases:
tracheostomy, pediatric, aerosol, nebulizer, breath-enhanced nebulizer, breath-activated
nebulizer, metered dose inhaler and vibrating mesh nebulizer. Relevant articles are presented in
two sections: (1) current practice for delivering aerosol through a pediatric tracheostomy and (2)
aerosol generators, which describes and compares different aerosol delivery devices including a
JN, a VMN, and pMDI. A discussion of in vitro comparison studies follows.
Current Practice for Delivering Aerosol Through a Pediatric Tracheostomy
There are no available recommendations for device and drug formulation selection for
spontaneously breathing pediatric patients with a tracheostomy. Therefore, Willis and Berlinski
(2012) developed a survey to describe patterns in current practice for delivering aerosol to this
population. They surveyed pediatric pulmonologists at U.S. hospitals. The survey addressed
institution characteristics, types of aerosol delivery devices and their administration technique,
types of inhalation medication and factors influencing device selection. The researchers had an
81% response rate (38 out of 47 institutions surveyed responded). Of these institutions, 68%
were freestanding children’s hospitals. Results showed diversity among institutions in how
aerosol to spontaneously breathing pediatric patients with a tracheostomy delivered. However,
the authors found little variation in practice between the freestanding children’s hospitals and the
other types of institutions. Most of the institutions used a nebulizer or a pMDI (97% and, 92%,
respectively). No institution reported using dry powder inhalers. Nebulizers were administered
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using both assisted and unassisted techniques. Although there was a discrepancy in the article
regarding the number of institutions using either technique, most of the institutions used the
unassisted technique with the nebulizer. The types of nebulizers used by the institutions were the
followings: JNs (34 institutions), breath actuated nebulizers (BAN, four institutions operated the
BAN continuously), breath-enhanced nebulizers (BEN, two institutions, one of which removed
the inspiratory valve), and VMNs (one institution). Furthermore, pMDIs were used with either an
assisted technique (32%, all of which used a spacer) or an unassisted technique (34% with 83%
of them using a valved holding chamber, while the remaining using spacer) or both techniques
(34%). The assisted technique was used by 68% of the surveyed institutions with either a
nebulizer or a pMDI. Of these, 38% used a flow-inflating bag only, 31% used a self-inflating bag
only, and 31% used both types of bags. As stated earlier, this survey showed that there was a
considerable variation among institutions in the practice of aerosol delivery to spontaneously
breathing tracheostomized children. However, it did not provide information about the most
efficient aerosol delivery method to this population. Thus, the authors stressed the need for
studies that compare the effect of using different aerosol devices and techniques on aerosol
deposition in this population.
Aerosol Generators
According to the Willis and Berlinski survey (2012) described above, several aerosol
generators are used to deliver inhaled medications to spontaneously breathing pediatric patients
with a tracheostomy, including JNs, BENs, BANs, VMNs and pMDIs with a spacer or valved
holding chamber. This section only describes the JN, VMN, and pMDI because these are the
aerosol generators that will be tested in this study. The advantages and disadvantages of these
generators will be reviewed to help respiratory care providers select the proper device for each
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individual patient. Finally, this section will examine in vitro studies that have compared the
effects of these aerosol generators on aerosol deposition in a spontaneously breathing pediatric
model with a tracheostomy.
Jet Nebulizer (JN)
A JN is used to convert an aqueous solution containing a medication into an aerosol form.
It is pneumatically operated by directing a pressurized gas created from a compressed gas source
through a restricted orifice called a jet. The high velocity of the gas flow creates a jet stream that
causes a sub-atmospheric pressure zone. This sub-atmospheric pressure draws liquid up the
capillary tube from the nebulizer reservoir and into the gas stream. In the gas stream, the liquid is
sheared into filaments that break up into droplets. These droplets can be further broken into small
particles by a baffle in the aerosol stream (Hess, 2008).
JNs can be used by any age group, including infants and small children, because they
require minimal cooperation from the patient to deliver the medications (Ari, Hess, Myers, &
Rau, 2009). They can be administered via either a mouthpiece or a face mask. The mouthpiece is
recommended for use with spontaneously breathing children who have intact airways, who are
more than three years old, and who are able to cooperate (Ari & Restrepo, 2012). The face mask
is an appropriate interface to be used with young children, particularly those under three years
old (Ari & Restrepo, 2012). A T-connector and tracheostomy collar are the interfaces that can be
used with JNs for children with artificial airways such as a TT.
A JN is also able to nebulize more than one drug or solution containing many drugs (Ari
et al., 2009). However, it requires a longer treatment time than other aerosol devices, a power
supply, and routine cleaning. Also, it wastes medication during exhalation (Ari et al., 2009).
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Vibrating Mesh Nebulizer (VMN)
VMNs use electricity to vibrate a mesh plate or aperture plate. The aperture plate
contains multiple funnel-shaped holes with the wider cross-section facing towards the
medication, and the narrower cross-section facing the place where the droplets emerge. The size
of these funnel-shaped holes controls the size and flow of the nebulized particles. As the aperture
plate begins to vibrate, the medication passes through the holes to generate aerosol. VMNs use
either vibrating mesh (eg., Aerogen Aeroneb, Nektar, San Carlos, CA; eFlow, Pari, Richmond,
Virginia) or a vibrating horn (eg., Omron, Omron Healthcare, Bannockburn, IL) to produce
vibrations in the aperture plate (Ari et al., 2009; Dhand, 2002; Hess, 2008).
A VMN is small, portable, and compact and operates silently. Also, it has a minimal
residual volume and a rapid nebulization rate, which means a faster nebulization time. On the
downside, it is more expensive than a JN, and it cannot nebulize drug suspensions or viscous
drugs, which can clog the holes. Moreover, it requires regular cleaning with gentle handling to
the mesh to prevent blockage of the holes (Rubin, 2011).
Pressurized Metered Dose Inhaler (pMDI)
pMDI is a pressurized canister containing a mixture of drug and propellant that is fitted to
a mouthpiece. Actuation of the canister opens a metering valve that releases a metered dose of
drug in aerosolized form under the force of a pressurized propellant (Newman, 2005). The pMDI
has many advantages. It is a small, portable, light, quiet, fast and relatively inexpensive device
(Hess, 2008; Rubin & Fink, 2005). On the other hand, large amount of the emitted pMDI drug
deposits in the oropharynx (Ari & Fink, 2011). In addition, many patients, especially young
children, have trouble synchronizing the actuation and inhalation (Ari & Fink, 2011). To
overcome the oropharynx deposition and/or synchronization issues, some patients use add-on
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devices such as a spacer or a valved holding chamber. A spacer is simply a tube without a valve
that captures aerosol from the pMDI (Hess, 2008). It reduces the amount of oropharynx
deposition, but it still requires synchronicity between the actuation and the patient's inhalation
(Rubin & Fink, 2005). By contrast, a valved holding chamber is a spacer device with a one-way
valve that holds the medication until the patient's inhalation is initiated and the valve is opened,
thus eliminating the need for synchronization between the actuation and patient's inhalation
(Rubin & Fink, 2005).
In tracheostomized patients, Newhouse (1999) reported that frequent actuation of a pMDI
directly into a long term tracheostomy leads to minor hemoptysis and accumulation of
granulation tissue on the carina and the adjacent bronchi. However, after placing an
AeroChamber attached to an infant mask between the pMDI and the tracheal stoma, the
pathologic changes and hemoptysis were gradually resolved.
Several articles have described modifications to standard MDI spacers (Meeker &
Stelmach, 1992; Mirza, Hopkinson, Malik, & Willat, 1999; Nakhla, 1997). All of these articles
agree that current spacers do not easily fit onto a TT, which leads to inadequate drug delivery to
the patients. Thus, simple modifications to standard MDI spacers are needed to make it easier to
attach the spacer securely to the TT. All of the modifications to a standard pMDI presented in
these articles were made to fit it to an adult TT. Monksfield (2008), in comparison, described the
modification of a standard pMDI spacer for a pediatric TT. By using accessible materials such as
a standard bladder irrigation syringe, he adapted a volumatic spacer (Allan and Hanburys) to fit
firmly into a pediatric TT. After the center of the barrel's syringe had been cut, it snugly attached
to the outflow end of the spacer because the barrel's diameter is appropriately the same size as
the spacer's outflow end. Then, the end of the irrigation syringe was connected to the TT. When
7	
  
	
  

Monksfield (2008) used this technique with his patient, compliance with bronchodilator therapy
increased and the need for nebulized steroids in combination with bronchodilators decreased.
In Vitro Comparisons
Different types of nebulizers can be used to administer albuterol to pediatric patients with
a tracheostomy. Berlinski and Hayden (2011) evaluated the effect of different aerosol devices on
albuterol delivery in a spontaneously breathing pediatric tracheotomy model. The authors studied
three different types of nebulizers: a continuous JN (Hudson), a BEN (Pari LC Plus) and a BAN
(Aeroclipse II). All the nebulizers were tested with the following two TT sizes and two breathing
patterns: tidal volume (Vt) = 80 ml, respiratory rate (RR) = 30 breaths/min, inspiratory to
expiratory ratio (I:E) = 1:3 with a TT size of 3.5 mm and Vt= 310 ml, RR= 20 breaths/min,
I:E=1:2 with a TT size of 5.5 mm. For the continuous JN, the authors studied three different
configurations: the JN alone, the JN with 15 cm of corrugated tubing attached to it, and a JN
connected to the corrugated tubing and a resuscitation bag. In each configuration, a T-piece and a
tracheotomy mask were tested. However, only the T-piece was tested with both the BEN and the
BAN. The albuterol deposition was collected via a filter placed at the carinal level of the
tracha/Trach model and was analyzed via a spectrophotometer at a wavelength of 276 nm. The
authors found almost no difference in albuterol deposition among the different configurations of
JN when the tracheostomy mask interface was used. The authors also reported that the highest
albuterol deposition occurred with the JN and T-piece in conjunction with the resuscitation bag
followed by the JN with the corrugated tubing; the lowest albuterol deposition occurred when the
JN was used alone (61±4, 39±8, and 25±3 µg, respectively, with a TT size of 3.5 mm; 71±23,
60±12 and 43±12 µg, respectively, with a TT size of 5.5mm). Berlinski and Hayden also
concluded that the T-piece was generally more efficient than the tracheostomy mask.
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Furthermore, the researchers reported that the BEN was more efficient when tested with a larger
Vt and a larger TT size (130±9 µg with Vt= 310 ml and a TT of 5.5 mm vs. 41±2 µg with Vt= 80
ml and a TT of 3.5 mm). However, the BAN was inefficient when tested with a low Vt (4±2 µg).
Although the authors studied different types of nebulizers, they did not compare the efficiency of
each aerosol device with the others. Comparing the efficiency of different types of nebulizers can
help to determine which is the most efficient for delivering aerosol to this population.
Ari et al. (2010) conducted an in vitro study to assess the impact of the aerosol device (JN
vs. VMN), position of the device on the ventilator circuit (prior to the humidifier vs. at the Ypiece) and bias flow (2 vs. 5 L/min) on aerosol drug delivery in simulated and mechanically
ventilated pediatric and adult lung models. The adult ventilator settings were as follows: a Vt of
500 ml, a positive end expiratory pressure (PEEP) of 5 cmH2O, a RR of 20 breaths/min, a peak
inspiratory flow (PIF) of 60 L/min and a descending ramp flow pattern. The pediatric ventilator
settings were a Vt of 100 ml, a PEEP of 5 cmH2O, a RR of 20 breaths/min and an inspiratory
time (Ti) of 1 second. The drug deposition was collected by an absolute filter distal to an 8 mm
(adult) and 5 mm (pediatric) endotracheal tube. The amount of drug deposition was measured via
spectrophotometry at a wavelength of 276 nm. Throughout this study, the VMN delivered the
highest inhaled mass percentage (23.8% ± 1.0) in the adult lung model when it was placed prior
to the humidifier with a 2 L/min bias flow. On the other hand, the JN delivered the least inhaled
mass percentage (3.8% ± 0.3) in the pediatric lung model when it was placed at the Y-piece with
a 5 L/min bias flow. In all positions, the inhaled mass of the VMN was two- to four fold greater
than with the JN in both lung models. The authors also noted that using higher bias flow with
both nebulizers tended to reduce aerosol drug delivery at both positions in the adult and pediatric
lung models. Deposition of the aerosol was similar for both nebulizers when they placed the
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devices at the Y-piece in the adult and pediatric lung models. When they placed the devices prior
to the humidifier, they found that deposition of aerosol was higher for the VMN in the adult
model than in the pediatric model.
Piccuito and Hess (2005) conducted an in vitro study to assess the impact of the aerosol
delivery device, interface, bias flow and humidification on albuterol delivery through a TT in a
spontaneous breathing adult model. The researchers conducted two experiments. The first
experiment used a nebulizer (Hudson, Temecula, CA) and the second used a pMDI (Monaghan,
Plattsburgh, NY). In the nebulizer experiment, four conditions of gas flow and humidification
were used. For the first condition, heated aerosol was generated using the nebulizer and a heater
with an outlet flow of approximately 30 L/min. The relative humidity was > 95%. The second
condition was heated humidity generated using a concha-Therm heated humidifier. The oxygen
outlet flow was approximately 30 L/min. The researchers set the heat of the humidifier to
provide a gas temperature of approximately 30˚C with a relative humidity > 95%. The third
condition was high flow without added humidity (approximately 30 L/min). For the fourth
condition, they attached the nebulizer to the TT without additional flow. In all four conditions,
the nebulizer was filled with 4ml of 2.5 mg albuterol and tested with both a T- piece/flex tube
and a tracheotomy mask. In the pMDI experiment, four conditions of gas flow and humidity
were also used: (1) heated humidity with a T- piece, (2) heated humidity with a tracheostomy
mask, (3) an AeroVent with a valved T-adapter, and (4) an AeroVent with a valved T-adapter
and a one-way valve proximal to the AeroVent. In all of these four conditions, four actuations of
the pMDI separated by ≥ 15 seconds were synchronized with the inhalation. In both experiments,
the simulated adult breathing parameters were a RR of 20 breaths/min, a Vt of 400 ml, and an
I:E of 1:2. A cuffed 8 mm TT was used. The aerosol delivered through the TT was captured by a
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filter placed between the lung model and the distal end of the TT. This study had six major
findings: (1) a measurable amount of albuterol aerosol was delivered through the TT with the use
of either the nebulizer or the pMDI with a spacer; (2) the delivery of albuterol using the
nebulizer with high gas flow was inefficient; (3) more albuterol was delivered when they used a
T-piece than when they used a tracheostomy mask; (4) the pMDI with a valved holding chamber
was more efficient than the nebulizer; (5) the pMDI was more efficient when a T-piece with a
valve was placed proximal rather than distal to the spacer; and (6) the impact of humidity on
aerosol delivery was not clear. In conclusion, albuterol delivery through a TT was affected by the
device, the interface and the bias gas flow.
In an in vitro study, Ari et al. (2012) compared aerosol delivery through a TT and an
endotracheal tube using different interfaces such as a tracheostomy mask, a T-piece and a
manual resuscitation bag in a simulated spontaneously breathing adult model. They concluded
that using the manual resuscitation bag increased lung dose by more than three- fold with either
the TT or endotracheal tube (45.75 ± 1.8% vs. 27.23 ± 8.98%, p = 0.038 and p = 0.025,
respectively). They also found that the tracheostomy mask had less inhaled dose than the T-piece
with the TT (6.92 ± 0.81%, p = 0.01). Overall, the authors found that delivering aerosol through
a TT was more efficient than through an endotracheal tube.
Aerosol delivery via a pMDI to spontaneously breathing tracheostomy pediatric patients
can be affected by many factors. Chavez and Berlinski (2010) conducted an in vitro study to
investigate whether the delivery device, the size of the TT and the patient’s breathing pattern
impact albuterol delivery via pMDI in a spontaneously breathing pediatric tracheostomy model.
They examined several delivery devices: an AeroChamber MV™, an AeroChamber Mini™, an
AeroTrach Plus™, a Medibag™, and a 6-inch tubing + Hudson™ adapter. These devices were
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tested without bagging. With each device, two sizes of TT (3.5 and 4.5 mm) and three breathing
patterns (16 months, 6 years old, and 12 years old) were tested. Furthermore, the Medibag™ and
6-inch tubing + Hudson™ adapter were also studied with synchronized bagging, and the
AeroChamber MV ™ was tested with both synchronized and asynchronized bagging. In all
experiments, 10 pMDI actuations were delivered for six respiratory cycles each. The amount of
albuterol was collected by a filter holder placed at the level of the carina. This amount was then
measured via spectrophotometry at 276 nm. The authors reported that a smaller TT size, manual
bagging and the breathing pattern of a younger child decreased the amount of albuterol reaching
the carina. Moreover, the AeroTrach Plus™ was generally the most efficient delivery device.
The effect of using a resuscitation bag on the delivery of aerosol via pMDI was further
studied by Chavez, Holt, Heullit, and Berlinski (2011). In an in vitro study, they evaluated the
effect of using a resuscitation bag in conjunction with a pMDI with a spacer during albuterol
delivery in a spontaneously breathing pediatric tracheostomy model. They studied two types of
valved holding chambers, an Aerochamber MV ™ and an AeroChamber Mini ™. Both valved
holding chambers were tested using different albuterol administration techniques via pMDI:
unassisted, synchronized assisted, and asynchronized assisted (on expiration or 1/s rate). In all
the tests, three different breathing patterns (16 months, 6 years old, and 12 years old) were
simulated. In each test, 10 pMDI actuations were delivered for six repeated cycles through a 4.5
mm TT. The authors reported that when synchrony and asynchrony (1s/rate) techniques were
used, albuterol delivery decreased for all the devices and breathing patterns. When the
researchers used asynchrony during expiration, albuterol delivery decreased only for the 16
months old breathing pattern. The authors found that using a resuscitation bag with a pMDI
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reduced the amount of aerosol delivered to the patients. This finding is similar to the previous
study by Chavez and Berlinski (2010).
In conclusion, this literature review has shown that there are many factors affecting the
delivery of albuterol through a TT, including the aerosol delivery devices, interfaces, bias flows,
administration techniques, and TT sizes used as well as the patients' breathing patterns. Several
findings from the research stand out. The most commonly used aerosol delivery devices with a
tracheostomy are nebulizers and pMDIs. However, research shows that a pMDI with a valved
holding chamber is more efficient than a nebulizer. The AeroTrach Plus is generally the most
efficient valved holding chamber for tracheostomy. BANs are inefficient when tested with low
Vt. BENs are more efficient when tested with large Vt. In terms of bias flow, nebulizers with
bias flow decreases albuterol delivery. In regard to interfaces, a T-piece is generally better than a
tracheostomy mask. When administering albuterol using the assisted technique with a nebulizer
increases albuterol delivery. On the other hand, using the assisted technique with a pMDI
decreases albuterol delivery. In regards to TT size, the amount of the albuterol delivery decreases
as the size of the TT decreases. Finally, breathing patterns affect delivery, with albuterol delivery
decreases among younger children.
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CHAPTER III
METHODOLOGY
Experimental Setup
As shown in Figure 1, to simulate spontaneous breathing for a two-year-old child with a
tracheostomy tube (TT), one side of a dual-chamber test lung with a lift bar (Training/test lung
[TTL] PneuView Systems, Adult/infant lung simulator, Michigan Instruments, Grand Rapids,
MI) was connected to the ventilator (Hamilton Medical AG, Rhäzüns, Switzerland). The other
side of the test lung was connected to the TT. Breathing parameters were set at an RR of 25
breaths/min, a Vt of 150 ml, a Ti of 0.8 second, and a PIF of 20 L/min (Lin et al., 2012). An
uncuffed TT (Shiley™, Covidien IIc, Mansfield, MA) with an inner diameter of 4.5 mm was
used because previous research has found it to be suitable for a two-year-old child (Wyatt,
Bailey, & Whiteside, 1999). The TT was attached to the collecting filter (Respirgard II, 303, vital
signs, Brooklyn, NY). Another filter was placed between the collecting filter and the opposite
side of the dual-chamber test lung to protect the test lung. The same experimental setup was used
in each trial of this study.

Figure 1. Experimental setup of the study.
14	
  
	
  

Aerosol Devices types, Doses and Operation
Three types of aerosol devices were tested in this study: (1) a JN (Micro Mist, Hudson
RCI, Temecula, CA), (2) a VMN (Aeroneb Solo, Aerogen, Galway, Ireland) and (3) a pMDI
(ProAir HFA, Teva Specialty Pharmaceutical, Horsham, PA).
The nebulizers (JN and VMN) were filled with albuterol sulfate (2.5mg/3 ml) (Nephron
Pharmaceuticals Corporation, Orlando, FL). The JN was operated with oxygen at 8 L/min, using
a calibrated flow meter. The unit-dose of albuterol sulfate solution was aerosolized by the JN
until the onset of sputter and by the VMN until no more aerosol was seen.
The pMDI canister, which contained albuterol sulfate (108 µg/actuation) was warmed to
hand temperature, shaken well, and primed with four actuations before each experimental run.
The pMDI was actuated at the onset of inspiration for a total of four puffs with more than15
seconds between each. All actuations were activated by the same investigator to minimize interoperator variability. Each experiment was repeated five times.
Administration Techniques
In this study, aerosol therapy was administered to the spontaneously breathing model
using two techniques: 1) assisted technique using a manual resuscitation bag in conjunction with
an aerosol device and 2) unassisted technique with direct administration from the aerosol device.
Unassisted Technique Setup
JN and VMN were administered as shown in Figure 2A and 2B, respectively. The Tpiece of the nebulizers was connected to another T-piece which was attached to the TT. A 6inch length of 22 mm ID corrugated tubing was placed on both open ends of the T-pieces.
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The pMDI was removed from the actuator and inserted into the nozzle inlet of a spacer
(Aerochamber HC MV, Trudell, London, Ontario, Canada). The pMDI + spacer was then
connected to the proximal part 15 mm adapter of the TT (Figure 2C).
Assisted Technique Setup
In the assisted technique, both JN and VMN were attached to a manual resuscitation bag
(Ambu SPUR II Disposable Resuscitator, Ambu Inc, Glen Burnie, MD) via a T-piece adaptor
that was connected to the TT through a 6-inch length of corrugated tube (Figure 2D and 2E,
respectively). The manual resuscitation bag was manually squeezed in synchrony with each
inspiration of the model. To ensure consistency with the spontaneous breathing model, all
breaths via the manual resuscitation bag were administered by a single investigator.
The pMDI + spacer was connected between the manual resuscitation bag and the TT.
(Figure 2F). Each actuation was synchronized with the beginning of inspiration. To ensure
consistency with the spontaneous breathing model, all pMDI actuations and the bagging were
delivered by the same investigator.
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Figure 2. Experimental setup with each aerosol device using assisted and unassisted techniques.
JN: Jet Nebulizer. VMN: Vibrating Mesh Nebulizer. pMDI: Pressurized Metered Dose Inhaler.

Measurement of Aerosol Deposition
Each aerosol device was tested five times using both administration techniques (n=5)
(Figure 3). In each trial, the amount of aerosol exiting the TT was captured by an absolute filter.
At the end of each trial, the deposited drug was eluted from the filter with 10 ml of 0.1 N
hydrochloric acid (JT Baker Company, Phillipsburg, NJ) using gentle agitation for 1 minute to
ensure proper mixing. The albuterol concentration was then analyzed with a spectrophotometry
(Beckman Instruments, Fullerton, CA) using a quartz cuvette, at a wavelength of 276 nm. The
spectrophotometer was calibrated prior to the trials via a holmium oxide filter (Beckman
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Instruments, Fullerton, CA) to determine wavelength accuracy. It was then set to zero before the
next trial by running only the solvent.

Aerosol Drug Delivery

Unassisted Technique

Assisted Technique

JN

VMN

pMDI

JN

VMN

pMDI

n=5

n=5

n=5

n=5

n=5

n=5

Figure 3. Organizational design of the study.

Data Analysis
The amount of drug deposited in the filter was quantified and reported as inhaled mass
and inhaled mass percentage. Data analyses were performed using the Statistical Package for the
Social Sciences (IBM SPSS, 18.0, Chicago, IL). Descriptive statistics including means and
standard deviations were computed for each aerosol device (JN, VMN, pMDI) for both the
assisted and unassisted techniques. A repeated measures test was performed to determine the
difference in the inhaled mass and inhaled mass percentage among the JN, the VMN and pMDI,
all together. Multiple comparisons were done to identify differences between aerosol devices
tested in this study using the assisted and unassisted techniques. A paired t-test was used to
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compare the	
  assisted with unassisted techniques on inhaled mass and inhaled mass percentage for
each aerosol device. In all comparisons, significance was defined as a p value < 0.05.
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CHAPTER IV
RESULTS
This study compared the amount of aerosol delivered to the TT (the inhaled mass) and
the inhaled mass percentage of three devices–a JN, aVMN, and a pMDI– using both an assisted
and unassisted techniques. Table 1 presents the means (± standard deviation) of albuterol mass
deposited on the filter and percent of nominal dose for JN and VMN and emitted dose for 4
actuations from the pMDI using the assisted and unassisted techniques.

Table 1.
Inhaled Mass (mg)

Inhaled Mass Percent (%)

JN

VMN

pMDI

JN

VMN

pMDI

0.13 ± 0.03

0.43 ± 0.03

0.18 ± 0.05

5.31 ± 1.59

17.45 ± 1.26

43.32 ± 12.38

0.15 ± 0.01

0.49 ± 0.07

0.20 ± 0.03

5.88 ± 0.77

19.77 ± 2.99

47.15 ± 7.82

Assisted
Technique
Unassisted
Technique

Efficiency of Aerosol Devices on Drug Delivery
This study found differences in the inhaled mass and inhaled mass percentage among the
three aerosol devices (p= 0.0001). There was also a statistically significant difference in the
inhaled mass and inhaled mass percentage between the JN and the VMN as well as between the
VMN and the pMDI when using both the assisted (p= 0.000, and p= 0.006, respectively) and the
unassisted techniques (p= 0.002, p= 0.004, respectively). The findings of this study showed no
significant difference between the JN and the pMDI in terms of inhaled mass when using either
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the assisted or unassisted technique (p=0.481, p=0.080, respectively). For inhaled mass
percentage, however, the difference was statistically significant when using both the assisted and
unassisted techniques (p= 0.008, p= 0.001, respectively). As shown in Table 1, the highest
inhaled mass was with the VMN, while the inhaled mass efficiency was greatest with the pMDI.
The JN was the least efficient device in both inhaled mass and inhaled mass percentage (Figure 4
and 5, respectively).
Efficiency of Aerosol Administration Techniques on Drug Delivery
While there was a trend towards higher inhaled mass and inhaled mass percentage with
unassisted vs. assisted technique, the differences between the two techniques were not
statistically significant for the JN, VMN and pMDI (p= 0.46, p= 0.19, and p= 0.64, respectively).

0.6

Inhaled	
   Mass	
  (µg)

0.5
0.4
0.3

Assisted	
  Technique

0.2

Unassisted	
  Technique

0.1
0
JN

VMN

pMDI

Aerosol	
  Delivery	
  Device

Figure 4. Differences in inhaled mass among aerosol delivery devices by delivery technique.
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Figure 5. Differences in inhaled mass percentage among aerosol delivery devices by delivery
technique.
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CHAPTER V
DISCUSSION
The purpose of this study was to evaluate the efficiency of the aerosol devices and the
administration techniques on the drug delivery to spontaneously breathing pediatrics with TT.
The percent of albuterol deposited distal to the TT was greater with the pMDI than VMN or JN.
The VMN was three fold more efficient than JN. In terms of administration technique, there was
no statistically significant difference on aerosol deposition between assisted and unassisted
techniques.
Efficiency of aerosol devices on drug delivery
When the pMDI was compared with the JN, we found that despite the smaller nominal
dose of the pMDI (432 µg) than the JN (2.5 mg), the amount of drug delivered to the TT was
more with the pMDI than the JN. These data are supported by Piccuito and Hess (2005), who
compared aerosol delivery between the JN and the pMDI in several conditions to the
spontaneously breathing adult with tracheostomy. In their study, they found that pMDI is more
efficient than JN in relation to the percentage of inhaled mass (21 ±1% vs. 15 ± 3%, p= 0.002).
However, they reported that the amount of inhaled mass was greater with JN than pMDI (382 ±
68 µg vs. 84 ± 4µg, p < 0.001), while this study found the opposite. The difference in the amount
of inhaled mass may attribute to the difference in the amount of fill volume in the JN given in
each study. The amount of fill volume of their study was 2.5 mg/4ml, while in this study was
2.5mg/3ml. According to Hess, Fisher, Williams, Pooler, and Kacmarek (1996) study, increasing
the amount of fill volume by adding more diluent volume will decrease the amount of drug
remaining in the JN after treatment ends and will increase the amount of inhaled medication.
Therefore, the higher fill volume in the JN of Piccuito and Hess study lead to an increase in the
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amount of the inhaled mass obtained by using the JN than our study. Additionally, the
administration setup of the JN was different between these two studies. Piccuito and Hess capped
one end of the JN’s T-piece, while the other end was attached to the T-piece interface via 15 cm
flex tube. In this study, one end of the JN’s T–piece was attached to the corrugated tube while
the other was connected to the T piece interface (Figure 2A). Capping one end of the JN’s Tpiece will increase the amount of the inhaled medication. This difference in the setup of the JN
administration contributes also to having higher inhaled mass with the JN in Piccuito and Hess
than this study.
When the VMN is compared to the JN, this study found that VMN is three fold more
efficient than JN. This result agrees with the findings of Ari et al. (2010), who evaluated aerosol
drug delivery in pediatric mechanically ventilated lung model with endotracheal tube. They
compared JN and VMN in different positions and bias flows. They found that drug delivery with
VMN was 2-4 fold greater than JN in pediatric lung models regardless of position and bias flow.
However, the inhaled mass percent of the JN and the VMN in their study was lower than this
study. This difference is not surprising since the type of the population tested in this study is
spontaneously breathing whereas mechanically ventilated in their study. Dolovich, Killian,
Wolff, Obminski, and Newhouse (1977) reported that the mean of the amount of aerosol
deposited in the lung with intermittent positive pressure ventilation was less than quite breathing
by 32% despite having the same drug dose in the ultrasonic nebulizer. Another factor that may
also attribute to the difference in the amount of aerosol deposition between these studies is the
type of the artificial airway used. This study used TT, while they used endotracheal tube. The TT
is shorter than the endotracheal tube which means lesser drugs will be lost in the tube. Ari et al.
(2012) reported that the TT is more efficient than the endotracheal tube in terms of drug delivery.
24	
  
	
  

Efficiency of aerosol administration techniques on drug delivery
This study found that adding a manual resuscitation bag to the aerosol device when
administrating bronchodilator (assisted technique) does not increase the amount of deposited
drug on the TT with all the studied aerosol devices. This result differs from the findings of Ari et
al. (2012). In an in vitro study, they evaluated the effect of using different patient interfaces such
as T-piece, tracheostomy collar and manual resuscitation bag on aerosol drug delivery through
TT and endotracheal tube. They concluded that using the manual resuscitation bag increased
lung dose by more than three fold with either TT or endotracheal tube. This difference may
account for the difference in breathing parameters, tracheostomy tube size and nebulizer type
used in both studies. While Ari et al (2012) used adult breathing parameters (Vt= 450 mL, RR=
20 breaths/min, I:E ratio 1:2) with 8 mm TT size, this study used pediatric breathing parameters
suitable for a 2 years old child (RR= 25 breaths/min, Vt= 150 ml, Ti= 0.8 second, and PIF= 20
L/min) with 4.5 mm TT size. The smaller Vt and higher RR with a smaller diameter TT would
be expected to reduce the amount drug deposited distal to the airway. They also used evalueMed
nebulizer, while this study used Hudson MicroMist nebulizer. Having different brands of
nebulizer may also account for the difference in the amount of deposited drugs.
Clinical Implications
This study provides good guidance to clinicians or caregivers regarding the relative
efficiency of these three aerosol delivery devices and the two administration techniques used
when administering aerosol therapy to spontaneously breathing pediatrics via TT. For the type of
aerosol delivery devices, the pMDI or VMN should be the first selection, making the selection of
the JN last option. However, there is no difference between assisted and unassisted aerosol
administration techniques when using any one of the aerosol devices. Consequently,
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administration technique selection can be determined by the patient comfort level, the need to
augment ventilation with a manual resuscitation bag for the specific patient.
Limitations
This experiment was an in vitro study. Thus, the results should be validated by an in vivo
study. In addition, the in vivo study provides more clinical responses in pediatric patients
receiving aerosol therapy with different aerosol devices and administration techniques. This
study only examined one type and size of the TT and resuscitation bag, as well as one set of
breathing parameters.
Future Research
For future studies, we suggest studying the effect of administration technique on aerosol
delivery to the pediatric patients by using other types of resuscitation bags, such as a flow
inflating bag. Different breathing patterns should be also studied in order to determine how
aerosol deposition would be affected by different diseases and patient conditions.
Conclusion
In this in vitro spontaneously breathing pediatric model, drug deposited distal to the TT
was influenced by the type of aerosol device used. JN was the least efficient device than both
VMN and pMDI. However, drug efficiency was similar with assisted and unassisted aerosol
administration techniques. The findings of this study could provide clinical guidance to the
health care providers or caregivers in selecting the best method to optimize drug delivery to
pediatric patients with TT.
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